Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon.

PubWeight™: 1.91‹?› | Rank: Top 3%

🔗 View Article (PMID 9509189)

Published in Trans R Soc Trop Med Hyg on April 08, 1998

Authors

L C Ranford-Cartwright1, J Taylor, T Umasunthar, L H Taylor, H A Babiker, B Lell, J R Schmidt-Ott, L G Lehman, D Walliker, P G Kremsner

Author Affiliations

1: Institute of Cell, Animal and Population Biology, University of Edinburgh, Scotland, UK.

Articles citing this

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother (2000) 3.58

A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One (2010) 3.50

History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev (2004) 3.40

pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother (2003) 1.59

Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. Lancet Infect Dis (2015) 1.44

Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother (2006) 1.36

Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob Agents Chemother (2003) 1.24

Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines. Antimicrob Agents Chemother (2005) 1.21

Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am J Trop Med Hyg (2010) 1.18

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Malar J (2009) 1.16

Development of reverse-transcription PCR techniques to analyse the density and sex ratio of gametocytes in genetically diverse Plasmodium chabaudi infections. Mol Biochem Parasitol (2007) 1.15

Frequent recombination events generate diversity within the multi-copy variant antigen gene families of Plasmodium falciparum. Int J Parasitol (2008) 1.13

Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother (1999) 1.09

Can estimates of antimalarial efficacy from field studies be improved? Trends Parasitol (2008) 1.07

Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria. Parasitol Res (2006) 0.96

Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data. Malar J (2011) 0.95

Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Malar J (2006) 0.88

No genetic bottleneck in Plasmodium falciparum wild-type Pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance. Antimicrob Agents Chemother (2007) 0.86

Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates. J Infect Dis (2006) 0.84

Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial. Malar J (2009) 0.84

Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Malar J (2015) 0.82

Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study. Malar J (2015) 0.80

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso. PLoS One (2016) 0.79

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali. Malar J (2015) 0.78

Comparison of different PCR protocols for the detection and diagnosis of Plasmodium falciparum. Parasitol Res (2005) 0.78

Analysis of genetic polymorphism in select vaccine candidate antigens and microsatellite loci in Plasmodium falciparum from endemic areas at varying altitudes. Acta Trop (2007) 0.78

Apparent bias for P. falciparum parasites carrying the wild-type pfcrt allele in the placenta. Parasitol Res (2010) 0.76

Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger. BMC Med (2016) 0.75

Genetic diversity of Plasmodium falciparum isolates from Baka Pygmies and their Bantu neighbours in the north of Gabon. Malar J (2015) 0.75

In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali. Am J Trop Med Hyg (2016) 0.75

Articles by these authors

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26

Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48

Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A (1988) 5.92

Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol (1999) 5.90

Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48

Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39

A computer-administered telephone interview to identify mental disorders. JAMA (1997) 5.31

Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23

An investigation of traveller's diarrhoea. Lancet (1970) 4.99

Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96

Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Philos Trans R Soc Lond B Biol Sci (2001) 4.68

Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 4.47

Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet (2004) 4.47

Population biology of multihost pathogens. Science (2001) 4.39

The ecology of genetically diverse infections. Science (2001) 4.37

Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet (2000) 4.32

A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05

Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med (1994) 3.72

Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med (2000) 3.68

Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57

Inhibition of interferon action by actinomycin. Biochem Biophys Res Commun (1964) 3.55

Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg (2001) 3.44

NYVAC: a highly attenuated strain of vaccinia virus. Virology (1992) 3.38

A study of Escherichia coli isolated from chronic urinary infection. J Med Microbiol (1969) 3.32

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06

High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03

Template switching by reverse transcriptase during DNA synthesis. J Virol (1990) 2.98

Using nurses for preventive activities with computer assisted follow up: a randomised controlled trial. BMJ (1989) 2.95

Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90

Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85

High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J Infect Dis (2001) 2.78

Immunization against Diphtheria with Alum-precipitated Toxoid-II. Br Med J (1942) 2.77

Psychotic illness following 'mabi bark tea' consumption. Br J Psychiatry (1992) 2.72

The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63

Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol (2000) 2.62

Comparison of influenza serological techniques by international collaborative study. Vaccine (1994) 2.55

Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A (1997) 2.54

A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53

MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J (1997) 2.52

Homologous recombination within subtelomeric repeat sequences generates chromosome size polymorphisms in P. falciparum. Cell (1988) 2.46

Cross-species interactions between malaria parasites in humans. Science (2000) 2.43

A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol (1994) 2.42

Transient Induction of Phenylalanine Ammonia-Lyase and 4-Coumarate: CoA Ligase mRNAs in Potato Leaves Infected with Virulent or Avirulent Races of Phytophthora infestans. Plant Physiol (1987) 2.36

Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36

Assembly of hepatitis delta virus particles. J Virol (1992) 2.36

Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans R Soc Trop Med Hyg (2001) 2.34

Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb Cortex (2001) 2.32

Enhanced production of reactive nitrogen intermediates in human and murine malaria. Parasitol Today (1995) 2.18

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18

Genetic diversity and dynamics of plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology (2000) 2.10

Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet (1997) 2.10

Immunisation with canarypox virus expressing rabies glycoprotein. Lancet (1992) 2.09

Rapid immune response to influenza vaccination. Lancet (1993) 2.09

Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science (1982) 2.09

Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05

Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03

Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03

No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Trans R Soc Trop Med Hyg (1999) 2.01

Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00

Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features. Intern Med J (2014) 1.98

Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis (1999) 1.96

Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun (2000) 1.94

Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J Virol (1992) 1.94

Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J Infect Dis (2000) 1.90

Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther (1992) 1.88

Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis (1996) 1.87

Malaria epidemiology in the province of Moyen Ogoov, Gabon. Trop Med Parasitol (1995) 1.85

The stability and properties of bimolecular lipid leaflets in aqueous solutions. J Theor Biol (1963) 1.80

Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg (1998) 1.80

Genetic structure and dynamics of Plasmodium falciparum infections in the Kilombero region of Tanzania. Trans R Soc Trop Med Hyg (1999) 1.79

Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78

Ketamine sedation for children in the emergency department. Emerg Med (Fremantle) (2001) 1.78

Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg (1998) 1.75

Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75

Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi--a rodent malaria model. Parasite Immunol (1990) 1.74

Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology (1994) 1.73

A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol (2001) 1.73

Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. Proc Natl Acad Sci U S A (1987) 1.72

Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Trans R Soc Trop Med Hyg (1981) 1.72

Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71

The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70

Genetic studies on Plasmodium chabaudi: recombination between enzyme markers. Parasitology (1975) 1.69

Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68